| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 03/25/2009 | CN100471856C Bicyclic compounds and compostions as PDF inhibitors |
| 03/24/2009 | US7507836 Benzamide modulators of metabotropic glutamate receptors |
| 03/24/2009 | US7507828 Such as quinoline-8-carboxylic acid [5-(2-mercapto-acetylamino)-pentyl]-amide; increasing sensitivity of cancer cells to radiotherapy cytotoxic effects; neurological diseases |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507755 Inhibitors of cathepsin s |
| 03/24/2009 | US7507747 Muscarinic acetylcholine receptor antagonists |
| 03/24/2009 | US7507744 Spiroazabicyclic heterocyclic compounds |
| 03/24/2009 | US7507572 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 03/24/2009 | US7507260 dyeing keratinous fibers, in particular human keratinous fibers such as hair, comprising, in an appropriate dyeing medium, at least one cationic direct dye of a given formula, and which is characterized in that it contains, in addition, at least one silicone chosen from the aminated silicones and resins |
| 03/19/2009 | US20090076023 Local Anesthetic Methods and Kits |
| 03/19/2009 | US20090075986 Anti-inflammatory medicaments |
| 03/19/2009 | US20090075924 antisense therapy; for diagnosis and treatment of atherosclerosis, hypercholesterolemia, or coronary artery disease |
| 03/19/2009 | US20090075873 Gastrin compositions and formulations, and methods of use and preparation |
| 03/19/2009 | US20090075271 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
| 03/19/2009 | US20090074819 Polymeric nano-shells |
| 03/18/2009 | EP2036564A1 The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 03/18/2009 | EP2036549A1 Novel Composition |
| 03/18/2009 | EP1565579B1 Methods for identifying risk of breast cancer |
| 03/18/2009 | EP1525473B1 Method for protein delivery into cells |
| 03/18/2009 | EP1513806B1 Sulphonic acid salts of mandelic acid derivatives |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP1040094B1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 03/18/2009 | CN101385851A Methods and compositions for healing and repair of articular cartilage |
| 03/18/2009 | CN101385732A Low dose entecavir formulation and use |
| 03/18/2009 | CN100469355C Nutritional supplements and methods of using same |
| 03/17/2009 | US7504501 Antiprotozoal imidazopyridine compounds |
| 03/17/2009 | US7504427 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 03/17/2009 | US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use |
| 03/17/2009 | US7504376 administering a beta-alanylhistidine dipeptide and a glycine, an insulin, an insulin mimic, or an insulin-action modifier to increase blood plasma concentrations of beta-alanine and/or creatine; dietary supplements and sports drinks. |
| 03/17/2009 | US7504247 2-O sulfatase compositions and methods of degradation therewith |
| 03/17/2009 | US7504237 Polynucleotides encoding interferon gamma polypeptides |
| 03/17/2009 | CA2322292C Compositions with low irritancy |
| 03/12/2009 | US20090069310 Anti-inflammatory medicaments |
| 03/12/2009 | US20090068642 Composition and pharmacology of novel alpha6-containing nicotinic acetylcholine receptors |
| 03/12/2009 | US20090068284 administering to the uterine cavity a plurality of physiologically inert beads bearing a tissue necrosing amount of silver nitrate as a solid silver ion source; |
| 03/12/2009 | US20090068203 Methods for treating cardiovascular disease using a soluble CTLA4 Molecule |
| 03/12/2009 | US20090068142 Compositions and methods for treating coronavirus infection and sars |
| 03/12/2009 | US20090068101 A1 Adenosine Receptor Antagonists |
| 03/11/2009 | EP1656129A4 Blockade of mtor to prevent a hormonal adaptive response |
| 03/11/2009 | CN101381339A Prodrugs of gaba analogs, compositions and uses thereof |
| 03/10/2009 | US7501512 Chemical compounds |
| 03/10/2009 | US7501425 e.g. 1-Methyl-7-[4-(pyrazol-1-yl)phenylamino]pyrimido[4,5-d]pyrimidin-2(1H)-one; anticarcinogenic agents; restenosis, angiogenesis and atherosclerosis |
| 03/10/2009 | US7501408 2-(R)-Cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-4-thiomorpholin-4-yl-butyramide; selective in presence of at least one other cathepsin isozyme; antiinflammatory agent: arthritis, atherosclerosis |
| 03/10/2009 | CA2547445C Systems and methods for altering vestibular biology |
| 03/05/2009 | US20090062362 Veterinary Formulation for Administration of a Water-Insoluble Drug to a Target Animal Through a Water Distribution System |
| 03/05/2009 | US20090062343 Polymorphic forms of 3-(4-amino-1-oxo-1, 3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 03/05/2009 | US20090062339 Compositions and methods for selective inhibition of nicotine acetylcholine receptors |
| 03/05/2009 | US20090062307 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents |
| 03/05/2009 | US20090060999 Protein formulation |
| 03/05/2009 | US20090060990 Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 03/05/2009 | US20090060989 Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 03/05/2009 | US20090060982 Methods and devices for the sustained release of multiple drugs |
| 03/03/2009 | US7498020 Medicaments |
| 02/26/2009 | WO2004096160A3 Vesicle-associated proteins |
| 02/26/2009 | US20090053707 Methods for lightening skin and hair |
| 02/26/2009 | US20090053332 Compositions for diabetes treatment and prophylaxis |
| 02/26/2009 | US20090053207 Methods and compositions for the prevention and treatment of genitourinary disorders, including pre-term labor and leiomyomas |
| 02/25/2009 | EP1680067B1 Composition for the cosmetic treatment of age-related dermatological symptoms |
| 02/25/2009 | EP1474117B1 Composition for inhalation |
| 02/25/2009 | CN101371923A BAFF receptor (BCMA), an immunoregulatory agent |
| 02/25/2009 | CN100463672C Method for preparing large quantity of micro-capsule |
| 02/24/2009 | US7495010 Muscarinic acetylcholine receptor antagonists |
| 02/24/2009 | US7494991 For microbial infections specially Gram-positive bacterial infection; atherosclerosis-associated disease |
| 02/24/2009 | US7494979 Method for treating congestive heart failure and other disorders |
| 02/24/2009 | US7494671 Extract of Trapa natans and methods of using the same |
| 02/24/2009 | US7494669 Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| 02/24/2009 | CA2462741C Dry liposomal pvp-iodine compositions |
| 02/24/2009 | CA2356151C Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 02/24/2009 | CA2354962C Composition for oxydation dyeing of keratin fibers containing one cationic amphiphile polymer, one oxyalkylene or polyglycerol high alcohol and one hydroxyl solvent |
| 02/19/2009 | US20090048327 Polymorphs of Pyrrole Substituted 2-Indolinone Protein Kinase Inhibitors |
| 02/19/2009 | US20090048301 Heterocyclic compounds and their use as anticancer agents |
| 02/19/2009 | US20090048270 Compounds, Methods And Devices for Inhibiting Neoproliferative Changes in Blood Vessel Walls |
| 02/19/2009 | US20090048180 Sustained-release preparation |
| 02/19/2009 | US20090048170 Target for anti-angiogenesis therapy |
| 02/18/2009 | EP2025227A1 Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom |
| 02/18/2009 | EP1554235B1 Process for synthesizing l-y-methylene glutamic acid and analogs |
| 02/18/2009 | EP0812184B2 Nitric oxide synthase inhibitors for topical use |
| 02/18/2009 | CN101366989A Dry powder inhalation system for transpulmonary dosage |
| 02/18/2009 | CN100462069C Valproic acid derivatives for the treatment of pain. |
| 02/17/2009 | US7491826 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 02/17/2009 | CA2535806C The use of hdac inhibitors for the treatment of cancer |
| 02/17/2009 | CA2347856C Dry powder for inhalation |
| 02/17/2009 | CA2138928C Immunoconjugates |
| 02/17/2009 | CA2121498C Recombitope peptides |
| 02/12/2009 | US20090042989 Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 02/12/2009 | US20090042925 Oxime substituted imidazoquinolines |
| 02/12/2009 | US20090042911 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-YL](3R,5S)-3, 5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 |
| 02/12/2009 | US20090042886 Benzamide Inhibitors of the P2X7 Receptor |
| 02/12/2009 | US20090042777 G-CSF Transferrin Fusion Proteins |
| 02/12/2009 | US20090041877 Composition comprising growth factor of xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 02/12/2009 | US20090041790 Methods for treating cardiovascular disease using a soluble CTLA4 molecule |
| 02/12/2009 | US20090041787 Chemokine receptor antagonists as therapeutic agents |
| 02/12/2009 | US20090041759 Materials and methods for treating ocular-related disorders |
| 02/12/2009 | US20090041746 Combination therapy with IgA1 proteases |
| 02/12/2009 | US20090041728 Proteoglycan Degrading Mutants for the Treatment of CNS |
| 02/11/2009 | EP2020991A2 A direct cellular energy delivery system |
| 02/11/2009 | EP1581307A4 Irs modulators |
| 02/11/2009 | EP1429800B1 Vaccine and use thereof for treatment of amyotrophic lateral sclerosis |
| 02/11/2009 | CN101362731A Heterocyclic compounds and methods of use |